Oriola Oyj
LSE:0NES
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Oriola Oyj
LSE:0NES
|
FI |
|
R
|
Royal Caribbean Cruises Ltd
XMUN:RC8
|
US |
|
3
|
3S Korea Co Ltd
KOSDAQ:060310
|
KR |
|
S
|
Sumitomo Pharma Co Ltd
DUS:DPM
|
JP |
Intrinsic Value
Is 0NES undervalued or overvalued?
See the intrinsic value estimate for Oriola Oyj and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
0NES looks undervalued.
But is it cheap by its own standards?
See how today’s valuation compares with 0NES’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Oriola Oyj Does
Oriola Oyj is a Nordic healthcare distributor that sits between drug makers and the places that sell or use medicines. It buys pharmaceuticals, health products, and related goods from manufacturers and moves them through its own logistics and distribution network to pharmacies, hospitals, and other healthcare customers, mainly in Finland and Sweden. In practice, it helps make sure medicines are stored, handled, and delivered under the rules that the healthcare market requires.
- Headquarters
- Finland FI
- Employees
- 800
- IPO date
- Jul 3, 2006
Latest Earnings Call
- EPS
- €0.01
- Expected
- €0.02
- Surprise
- −50.0%
- Stock, next trading day
- −2.6%
Revenue & Expenses Breakdown
Oriola Oyj
Earnings Waterfall
Oriola Oyj
The intrinsic value for Oriola Oyj (0NES) under the Base Case is hidden EUR.
Compared with the current market price of 0.771 EUR, the stock appears hidden.